Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -3.689% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCCNC(=O)c1ccc2c(=O)c(O)c(-c3ccsc3)[nH]c2c1
b.) Cc1ccc(N2CC(C(=O)NC3CCC(C)CC3)CC2=O)cc1
c.) COc1ccc2c(c1OC)C(=O)N(c1ccc(C)cc1)C2=O
Answer: a. CCCNC(=O)c1ccc2c(=O)c(O)c(-c3ccsc3)[nH]c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1ccc2c(=O)c(O)c(-c3ccsc3)[nH]c2c1
CCCNC(=O)c1ccc2c(=O)c(O)c(-c3ccsc3)[nH]c2c1
3-hydroxy-4-oxo-N-propyl-2-thiophen-3-yl-1H-quinoline-7-carboxamide